FAXTENOR Trademark

Trademark Overview

On Wednesday, November 8, 2000, a trademark application was filed for FAXTENOR with the United States Patent and Trademark Office. The USPTO has given the FAXTENOR trademark a serial number of 76161549. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 21, 2014. This trademark is owned by AstraZeneca AB. The FAXTENOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in the treatment of diseases and disorders of the central nervous system, the peripheral nervous system, the urinary system and the cardiovascular system, none being for anti-cancer uses or purposes; pharmaceutical preparations and substances for pain control and anaesthesia, none being for anti-cancer uses or purposes
faxtenor

General Information

Serial Number76161549
Word MarkFAXTENOR
Filing DateWednesday, November 8, 2000
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 21, 2014
Registration Number3278260
Registration DateTuesday, August 14, 2007
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 29, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in the treatment of diseases and disorders of the central nervous system, the peripheral nervous system, the urinary system and the cardiovascular system, none being for anti-cancer uses or purposes; pharmaceutical preparations and substances for pain control and anaesthesia, none being for anti-cancer uses or purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 21, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSE

Trademark Events

Event DateEvent Description
Friday, March 21, 2014CANCELLED SEC. 8 (6-YR)
Tuesday, August 14, 2007REGISTERED-PRINCIPAL REGISTER
Monday, July 23, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 23, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 29, 2007PUBLISHED FOR OPPOSITION
Wednesday, May 9, 2007NOTICE OF PUBLICATION
Tuesday, April 24, 2007NOTICE OF ALLOWANCE CANCELLED
Friday, March 30, 2007ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Thursday, March 29, 2007PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Wednesday, March 28, 2007ASSIGNED TO PETITION STAFF
Thursday, March 22, 2007PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED
Thursday, March 22, 2007PAPER RECEIVED
Thursday, October 5, 2006EXTENSION 5 GRANTED
Thursday, October 5, 2006EXTENSION 5 FILED
Thursday, October 5, 2006TEAS EXTENSION RECEIVED
Thursday, April 20, 2006EXTENSION 4 GRANTED
Thursday, April 20, 2006EXTENSION 4 FILED
Thursday, April 20, 2006TEAS EXTENSION RECEIVED
Wednesday, November 23, 2005EXTENSION 3 GRANTED
Thursday, October 27, 2005EXTENSION 3 FILED
Friday, October 28, 2005EXTENSION RECEIVED WITH TEAS PETITION
Friday, October 28, 2005PETITION TO REVIVE-GRANTED
Friday, October 28, 2005TEAS PETITION TO REVIVE RECEIVED
Wednesday, April 27, 2005EXTENSION 2 GRANTED
Wednesday, April 27, 2005EXTENSION 2 FILED
Wednesday, April 27, 2005TEAS EXTENSION RECEIVED
Friday, November 12, 2004EXTENSION 1 GRANTED
Wednesday, October 27, 2004EXTENSION 1 FILED
Wednesday, October 27, 2004TEAS EXTENSION RECEIVED
Monday, June 28, 2004CASE FILE IN TICRS
Tuesday, April 27, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 23, 2004OPPOSITION TERMINATED NO. 999999
Monday, February 23, 2004OPPOSITION TERMINATED NO. 999999
Monday, February 23, 2004OPPOSITION DISMISSED NO. 999999
Tuesday, October 7, 2003PAPER RECEIVED
Wednesday, April 24, 2002OPPOSITION INSTITUTED NO. 999999
Wednesday, February 27, 2002EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 22, 2002PUBLISHED FOR OPPOSITION
Wednesday, January 2, 2002NOTICE OF PUBLICATION
Wednesday, November 8, 2000SEC. 44(D) CLAIM DELETED
Wednesday, October 24, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 26, 2001LETTER OF SUSPENSION MAILED
Wednesday, March 21, 2001ASSIGNED TO EXAMINER

Related Keywords

faxtenor system uses pharmaceutical cancer being none nervous purposes anti preparations